← Back

Criteria Capital Risc | Criteria Bio Ventures and Criteria Venture Tech

vc$350.5MCo-investsLeads rounds

Fund Size

$350.5M

Location

Spain

Activity

Statusactively investing

Links

Share this fund

Investment Thesis

Invests in early-stage biotechnology, healthcare, and technology companies, with emphasis on transformative B2B SaaS, deep tech, software infrastructure, data, IoT, insurtech, cybersecurity, and life sciences.

About Criteria Capital Risc

Two specialized investment vehicles under Criteria Capital Risc focused on BioTech/health and DeepTech respectively. Plans to invest €300 million in early-stage companies primarily in Spain and Portugal with selective investments in Europe and North America.

Sectors

BiotechDigital HealthCybersecuritySemiconductors

Stages

pre-seedseedseries-a

Geography Focus

EuropeNorth AmericaPortugalSpain

Team

NameTitleRoleLinks
Marcelino ArmenterChairmansenior
Pablo Cironi, PhDDirector Investment

Notable Investments

8LayersCytospire TherapeuticsAdaptam TherapeuticsNRG TherapeuticsMinoryx TherapeuticsAboleris PharmaTolerance BioNanusens

Traits

Leads rounds

Co-invests

FAQ

What does Criteria Bio Ventures and Criteria Venture Tech invest in?

Criteria Bio Ventures and Criteria Venture Tech invests in Biotech, Digital Health, Cybersecurity and Semiconductors at the pre-seed, seed and series-a stages.

Which geographies does Criteria Bio Ventures and Criteria Venture Tech focus on?

Criteria Bio Ventures and Criteria Venture Tech focuses on Europe, North America, Portugal and Spain, and is headquartered in Spain.